csirt@kutim:~/threat-intel/cve/CVE-2026-33554

Katalog CVE

CVSS 7.5 · High EPSS 0,40%

Kerentanan Stack-based Buffer Overflow. Skor CVSS 3.1 7.5 (High) menurut mitre.org.

Deskripsi (NVD)

ipmi-oem in FreeIPMI before 1.6.17 has exploitable buffer overflows on response messages. The Intelligent Platform Management Interface (IPMI) specification defines a set of interfaces for platform management. It is implemented by a large number of hardware manufacturers to support system management. It is most commonly used for sensor reading (e.g., CPU temperatures through the ipmi-sensors command within FreeIPMI) and remote power control (the ipmipower command). The ipmi-oem client command implements a set of a IPMI OEM commands for specific hardware vendors. If a user has supported hardware, they may wish to use the ipmi-oem command to send a request to a server to retrieve specific information. Three subcommands were found to have exploitable buffer overflows on response messages. They are: "ipmi-oem dell get-last-post-code - get the last POST code and string describing the error on some Dell servers," "ipmi-oem supermicro extra-firmware-info - get extra firmware info on Supermicro servers," and "ipmi-oem wistron read-proprietary-string - read a proprietary string on Wistron servers."

Rincian

Terbit di NVD
24 Maret 2026
Terakhir diubah
17 Juni 2026
Status NVD
Deferred
CVSS 3.1
7.5 (High), sumber mitre.org
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-121: Stack-based Buffer Overflow
EPSS (30 hari)
0,40% peluang dieksploitasi; lebih tinggi dari 32,7% CVE lain

Produk dan versi terdampak

NVD belum mencantumkan data produk (CPE) untuk CVE ini. Produk yang terdampak biasanya disebut di deskripsi dan di advisory vendor pada daftar referensi.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.